Parts of a whole analysis visualizing the relative distribution of <i>T. colubriformis</i> L3 in each height zone. by Katy A. Martin (9216905)

Correlation between decreased ferroportin (Fpn) protein level and increased hepcidin (Hepc) mRNA expression in the liver of <i>ms/−</i> males. by Małgorzata Lenartowicz (150659)

Lubrication Behavior of Fullerene-Coated Nanoparticles on Rough Surfaces by Guangchao Han (1453198)

Viral inhibition assays around the IC50 of VPA by direct inhibition of HDAC2. by Amanda Watson (4447267)

Determination of IC₅₀ and maximum induction of VPA using Vero cells. by Amanda Watson (4447267)

Netrin-1 overexpression increases HCV RNA and specific infectivity of HCV virions in vitro whereas Netrin-1 depletion decreases HCV RNA and specific infectivity in vitro. by Marie-Laure Plissonnier (337713)

“…<b>L</b>. Netrin-1 depletion decreases specific infectivity of virions. Specific infectivity was calculated for each collected fraction using the TCID₅₀/HCV RNA ratio. …”

LuxR G37V has decreased DNA-binding activity. by Chelsea A. Simpson (9579303)

The number of strong contact and strong contact force of CFRP confined concrete specimens under three coal gangue replacement rates (0%, 50%, 100%). by Qingwen Li (1510687)

The number of strong contact and strong contact force of GFRP confined concrete specimens under three coal gangue replacement rates (0%, 50%, 100%). by Qingwen Li (1510687)

The number of strong contact and strong contact force of BFRP confined concrete specimens under three coal gangue replacement rates (0%, 50%, 100%). by Qingwen Li (1510687)

Eliminations of dorsal projections in DOM and DOM-A downregulation were due to reduced number of sLNvs and decrease of PDF. by Zhenxing Liu (399809)

(A) Spike patterns of 50 granule cells (GR; top) and Golgi cells (GO; bottom) by Tadashi Yamazaki (40072)

The descriptive statistics for arsenic (As) in micrograms per liter (μg/L), dissolved oxygen (DO; O_2(aq)) in milligrams per liter (mg/L), oxidation-reduction potential (... by Seth H. Frisbie (7821866)

Antioxidation and Anti-Inflammatory Activity of Prussian Blue Nanozymes to Alleviate Acetaminophen-Induced Acute Liver Injury by Qiang Feng (88137)

Subjects:

Simulations that now also include a <i>symmetric</i> indoors/outdoors model, with a threshold temperature of 17.5C both in spring and in fall. by Sebastian A. Müller (10688740)

Study Data. by Jonathan S. Jahr (2709088)

“…The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …”

Study outcomes. by Jonathan S. Jahr (2709088)

“…The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …”

Patient characteristics. by Jonathan S. Jahr (2709088)

“…The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …”

OCA alone markedly decreases and combined with Gemcitabine or Cisplatin abrogates growth of iCCA xenografts. by S. Di Matteo (6260417)

“…After 4 weeks, when the tumor size was approximately 100 mm³ (T₀) mice were treated with OCA (0.03% w/w, 30 mg/kg) alone or combined with Cisplatin (2.4 mg/Kg in 100 μl) or Gemcitabine (1.05 mg/Kg in 100 μl) for 5 additional weeks. a) Results are expressed as percent increase in tumor volume at different time points. …”

Example of a dependent variable. by Shinya Fukui (19259648)